Developer docs
API playgroundTry for free, no card

Search company profiles

Benchling

Full company profile

uuid000085m

Namestring
Benchling
Legal namestring
Benchling
Websiteurl
benchling.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Benchling is a San Francisco-based cloud software company founded in 2012 that provides a unified R&D platform purpose-built for biotechnology and pharmaceutical organizations. Its platform combines electronic lab notebook (ELN), laboratory information management system (LIMS), biological registry, inventory management, molecular biology tools, and workflow automation in a single biologically-aware data model, with 1,300+ customers and 200,000+ scientists using the system, including 75% of the top 25 biopharma companies. The product portfolio spans Benchling Bioresearch (core R&D workspace), Benchling Bioprocess (process development), Benchling Biologics (antibody R&D with no-code format design), Benchling In Vivo (preclinical study management), Benchling Automation (lab instrument connectivity with 200+ integrations), Benchling Connect, Benchling Insights, and Validated Cloud for regulated environments.

The company's technology architecture is built on structured, entity-aware data capture that links experiments, samples, sequences, and results at the point of record, providing the foundation for its 2026 AI suite: Benchling AI, the "AI Scientist" autonomous agent, Model Hub (hosting AlphaFold, Chai-1, Boltz-2, OpenFold), Benchling Inference (managed GPU capacity via Baseten), and MCP-based AI Connectors integrating with Notion, SharePoint, Snowflake, and major LLM providers. Acquisitions of Overwatch Research (2022), PipeBio (2024), and ReSync Bio (2025) extended capabilities into in vivo, antibody bioinformatics, and AI tooling respectively.

Benchling monetizes primarily through multi-year SaaS subscriptions priced per user license, supplemented by tiered Premier and Enterprise Premier success packages, professional services, certified implementation partners, and a free academic tier that seeds enterprise pipeline. Reported ARR is $200M (2024), with a $6.1B last-disclosed valuation. The company is privately held, headquartered at 680 Folsom St. in San Francisco, and maintains SOC 2 Type 2, ISO 27001, GDPR, and FDA 21 CFR Part 11 compliance.

Short descriptiontext

Benchling is a cloud-based R&D platform that combines ELN, LIMS, biological registry, and lab automation for biotech and pharmaceutical organizations. It serves 1,300+ customers—including 75% of the top 25 biopharma—and 200,000+ scientists, monetizing via multi-year SaaS subscriptions and reaching $200M ARR in 2024.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lab informatics platform, electronic lab notebook, biotech R&D software, biologics discovery platform, lab automation software
Industry3 codes
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAMAI
Lab Middleware, Instrument Connectivity & Automation
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
Product category
Biotech R&D Software Platform
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS/Cloud Platform Subscription
TypeSubscription Recurring
Description

Benchling operates as a cloud-based SaaS platform for biotech R&D, providing subscription-based access to its integrated ELN, LIMS, molecular biology tools, and AI capabilities. Enterprise pricing varies by organization size and required features.

benchling.com
2Professional Services & Implementation
TypeProfessional Services
Description

Benchling offers professional implementation services, technical advisory, and architecture reviews through Premier Success Packages. These paid services complement the core platform subscription.

benchling.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details4 tiers
1Standard Success Package
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Included with all Benchling licenses. Provides 8 hours/week product support coverage, 5 days/week; self-serve help center; foundational customer success program.

benchling.com
2Premier Success Package
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Paid based on number of user licenses. 24 hours/day, 5 days/week support with faster response time; custom training courses; Customer Success Manager with monthly consultation; access to Optimization Services.

benchling.com
3Enterprise Premier Success Package
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Paid based on number of user licenses. 24 hours/day, 7 days/week support with Named Benchling Product Support Analyst; Customer Success Manager with weekly consultation; Named Enterprise Solutions Architect access.

benchling.com
4Academic Free Plan
ModelFreemiumBilling cadenceMonthly
Notes

Free academic plan with core ELN and molecular biology tools. Benchling AI also available free for academic scientists.

benchling.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 14 records shown
1Benchling Bioresearch
Description

Digital workspace for biotech R&D - electronic lab notebook, sample management, and molecular biology tools

benchling.com
+13 more records
Core offering1 text field

Benchling provides a cloud-based R&D platform purpose-built for biotechnology and pharmaceutical research organizations. The platform unifies electronic lab notebook (ELN), laboratory information management system (LIMS), molecular biology design tools, biological registry, inventory management, and workflow automation in a single biologically-aware system. The offering includes AI capabilities, lab automation, and process development tools sold as modular products to enterprise biotech companies, with paid subscription and professional services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 63% reduction in time spent on data capture, search, and collection (Gilead)
+7 more records
Product overview1 text field

Benchling is a cloud-based R&D platform providing a unified, modular architecture for biotech research. The core platform consists of Benchling Bioresearch (digital workspace combining ELN, LIMS, molecular biology tools, registry, and inventory), Benchling Bioprocess (process development for recipe design and batch execution), Benchling AI (unified AI interface with scientific model access and agents), Benchling Biologics (antibody R&D with no-code format design and automated characterization), Benchling In Vivo (in vivo study management), and Benchling Automation (lab instrument connectivity). Supporting modules include Benchling Connect (200+ instrument integrations), Benchling Registry (molecular data management), Benchling Insights (analytics), Model Hub (AI model library), and Benchling Inference (GPU capacity). Acquired brands include PipeBio Antibodies (high-throughput antibody analysis). Solution packages target specific modalities including gene therapy, cell therapy, antibodies, RNA therapeutics, agritech, industrial biotech, and microbial strains. Services include Professional Services, Customer Success, and Learning Labs.

Product and service14 records
1Benchling Bioresearch
CategoryCore platform
Description

Digital workspace for biotech R&D providing a shared space to design and manage experiments, complex biomolecules, workflows, and results end-to-end. Combines ELN, LIMS, molecular biology tools, biological registry, inventory management, and workflow automation in one platform. Targeted at biotech and pharmaceutical research organizations.

2Benchling Bioprocess
CategoryCore platform
Description

End-to-end process development platform for recipe design, experiment planning, batch execution, and analysis. Built with ISA-88/ASM-compatible data models supporting multi-factor experiments, guided batch execution, and data science readiness. Targeted at bioprocess development teams.

3Benchling AI
CategoryCore platform
Description

Unified AI interface built directly into the Benchling notebook. Scientists describe what they need and Benchling AI handles it, grounded in their own structured R&D data. Includes access to scientific AI models, agents (Notebook Check, SQL Writer, Data Entry Agent, Deep Research Agent, Experiment Optimization), and chat capabilities. Targeted at biotech R&D scientists.

4Benchling Biologics
CategoryCore platform
Description

End-to-end platform for antibody R&D providing no-code antibody format design and automated registration at scale. Features format-aware data model, automated sequence characterization (CDR/FR annotation, germline gene identification, liability detection), and lineage tracking for complex protein formats. Targeted at antibody discovery and protein engineering teams.

5Benchling In Vivo
CategoryCore platform
Description

In vivo study management software for managing preclinical studies from study design and animal randomization through data capture, analysis, and reporting. Replaces paper records and fragmented spreadsheets with modern collaborative digital system. Targeted at preclinical research and animal study teams.

6Benchling Automation
CategoryCore platform
Description

Lab instrument automation platform that connects lab instruments to scientific records, runs analysis automatically, and feeds every result directly into the next decision. Hardware-agnostic with over 200 instrument connectors and visual workflow design. Targeted at labs seeking to automate data capture and analysis.

7Benchling Registry
CategoryCore platform
Description

Comprehensive registry system for modeling, organizing, and recording data for all molecules including biomolecules, small molecules, cell lines, animals, and reagents. Provides molecular lineage tracking, automatic metadata computation (weight, isoelectric point, Log P, TPSA), and uniqueness constraints. Targeted at biotech R&D organizations managing biological entities.

8Benchling Validated Cloud
CategoryCompliance offering
Description

Compliance-focused cloud offering helping teams move faster without compromising compliance. Provides validation and compliance support for tech transfer between R&D phases and assembles regulatory data packages faster. Supports FDA 21 CFR Part 11 compliance with electronic signatures and audit trails. Targeted at regulated biotech and pharmaceutical customers.

9Model Hub
CategoryAI infrastructure
Description

Dedicated space within Benchling R&D platform for scientists to discover, run, and track scientific AI models alongside experimental data without requiring separate infrastructure. Features curated model library including AlphaFold 2, Chai-1, Boltz-2, OpenFold 2, and OpenFold 3, with 4x increase in prediction speed through upgraded GPU infrastructure. Targeted at biotech R&D scientists.

10Benchling Inference
CategoryAI infrastructure
Description

Scalable GPU capacity service enabling biotech teams to train and run scientific AI models without managing infrastructure. Built on Baseten's inference stack across 15+ cloud providers with 5-10 second cold starts. Targeted at biotech R&D teams needing AI compute capacity.

11PipeBio Antibodies
CategoryAcquired product
Description

Bioinformatics platform specializing in high-throughput antibody analysis. Handles upstream sequence analysis including NGS and Sanger data processing, clustering candidates, screening liabilities, and developability scoring. Integrated with Benchling Biologics. Targeted at antibody discovery teams.

12Customer Success
CategoryService
Description

Expert guidance and support services including product training, advisory services, customer success management, and success packages (Standard, Premier, Enterprise Premier) with varying support levels. Targeted at enterprise biotech and pharmaceutical customers.

13Professional Services
CategoryService
Description

Implementation and consulting services covering design and configuration, onboarding and training, integration development, and compliance and validation. Includes support for IQ, OQ, and PQ/UAT requirements. Targeted at enterprise customers deploying Benchling.

14Benchling Learning Labs
CategoryService
Description

Flexible on-demand learning platform offering courses and role-specific badges for Benchling users, administrators, developers, and consultants. Includes learning plans and certification programs. Targeted at Benchling customers and partners.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-23
Description

NVIDIA's BioNeMo Agent Toolkit at Bio International Convention transforms LLMs into domain-specific AI agents for end-to-end biology and chemistry workflows. Benchling participates in this ecosystem for AI-driven drug discovery.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-28
Description

HighRes partnership for Benchling Automation, enabling standardized integrations with workcell robotics. The collaboration solves decades-old infrastructure problems for connecting robots to scientific records.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-28
Description

Automata partnership for Benchling Automation, providing end-to-end lab orchestration capabilities integrated with Benchling's scientific record system.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-28
Description

Celltrio partnership for Benchling Automation, providing workcell fleet management integrated with Benchling's instrument connectivity.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-28
Description

Opentrons partnership for Benchling Automation, integrating bench liquid handlers into Benchling's scientific record system for automated data capture.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-28
Description

Hamilton partnership for Benchling Automation, integrating advanced liquid handling platforms with Benchling's scientific record and workflow automation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-20
Description

Benchling and Baseten partnered to launch Benchling Inference, a scalable GPU capacity service enabling biotech teams to train and run scientific AI models without managing infrastructure. Built on Baseten's inference stack across 15+ cloud providers with 5-10 second cold starts.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-13
Description

Boltz PBC partnership to expand Benchling's curated model library with specialized scientific AI models accessible within Benchling's workflow.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-06
Description

Benchling integrated with Twist Bioscience for One-Click Ordering, allowing scientists to design experiments, submit DNA/synthesis orders, and receive structured results without leaving the Benchling platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-06
Description

Benchling integrated with Adaptyv for protein engineering services ordering, enabling scientists to design constructs, place orders, and receive structured results directly in the Benchling workflow.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-06
Description

Benchling integrated with Ginkgo Bioworks for automated data quality and biological services. Integration creates continuous feedback loop tying orders to experimental context with results flowing back as structured, searchable data.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-08
Description

Benchling announced strategic collaboration with Lilly TuneLab (Eli Lilly's AI/ML platform) to provide predictive research models to scientists. Lilly makes models trained on over $1 billion in research investment available to Benchling's network of 1,300+ biotech companies for antibodies and small molecules.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-20
Description

Benchling partnered with Anthropic to integrate Claude AI into biotech research through the Claude for Life Sciences Ecosystem. The collaboration enables scientists to utilize AI for data analysis, decision-making, and research workflow automation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-14
Description

NVIDIA partnership for AI infrastructure, including integration with NVIDIA BioNeMo models and GPU capacity for Benchling's scientific AI capabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-21
Description

Benchling acquired ReSync Bio, which provided scientists with no-code access to advanced AI tools through partnerships and open-source tools like Boltz and REINVENT4. ReSync sunset its platform and transitioned customers to Benchling.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-11
Description

Benchling and Merck collaboration on vaccine bioanalysis, implementing an integrated software platform for bioanalytical workflows focusing on increasing speed, streamlining processes, and maintaining standards in vaccine development.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-05-07
Description

Benchling and Moderna expanded collaboration to bring hundreds of Moderna scientists onto a unified, AI-ready R&D digital platform. Focus on consolidating research systems, automating scientific workflows, and standardizing data into AI-ready formats as a digital transformation initiative.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-20
Description

Benchling acquired PipeBio, a bioinformatics company specializing in high-throughput antibody analysis. The acquisition integrates PipeBio's capabilities in antibody screening and AI-driven analysis to enhance Benchling's biologics discovery platform for drug discovery and design.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-10
Description

Benchling and Novonesis forged a long-term partnership to power R&D innovation. Novonesis, a major biosolutions company, uses Benchling across 1,500 employees globally to accelerate research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-02-24
Description

Benchling acquired Overwatch Research, a Belfast-based software startup focused on preclinical biopharma research. The acquisition aimed to develop a comprehensive in vivo solution for drug discovery, accelerate preclinical development, and expand Benchling's European presence.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dotmatics provides a scientific R&D data platform spanning ELN, LIMS, and data lakes for life sciences. Both Benchling and Dotmatics are explicitly building in the 'experimental data lake' space for biotech R&D, making them the most direct competitors in the unified R&D informatics category.

TypeDirect peer
Description

LabWare is a long-standing LIMS/ELN provider used by many life sciences organizations. It directly competes with Benchling's Bioresearch and Bioprocess modules, particularly in regulated and process-development environments.

TypeDirect peer
Description

LabVantage delivers LIMS and laboratory informatics solutions to pharma, biotech, and manufacturing customers. It is a frequent enterprise alternative to Benchling in LIMS-heavy deployments.

TypeDirect peer
Description

Genedata provides scientific informatics platforms for biopharma R&D, including biologics, screening, and bioprocess workflows. Its domain-specialized approach makes it one of the closest direct competitors to Benchling Biologics and Bioprocess.

5Sapio Sciences
TypeDirect peer
Description

Sapio Sciences offers a unified lab informatics platform combining LIMS, ELN, SDMS, and scientific data management. Its platform strategy overlaps directly with Benchling's unified biology-aware approach.

TypeDirect peer
Description

IDBS provides ELN and scientific data management software for biopharma R&D, now part of Revvity (formerly PerkinElmer). It competes in the same biological R&D informatics category as Benchling, especially with enterprise biopharma.

TypeBroad incumbent
Description

Revvity is a large life sciences and diagnostics company with an informatics portfolio (including IDBS). As a broad incumbent, it can bundle informatics with instruments, reagents, and services in ways Benchling cannot match from a pure-software position.

TypeBroad incumbent
Description

Thermo Fisher offers informatics products such as SampleManager and Chromeleon, alongside the industry's broadest lab-instrument portfolio. It competes with Benchling especially in instrument-connected workflows and within large-pharma accounts.

9Arxspan (Certara)
TypeDirect peer
Description

Arxspan, part of Certara, provides cloud-based electronic lab notebook and scientific data management software. It targets the same biology and chemistry research lab segments as Benchling Bioresearch.

TypeOthers
Description

Veeva is a leading cloud platform for life sciences with regulatory, clinical, and quality solutions. While not a direct R&D informatics competitor, it shares the same strategic customer base (top biopharma) and competes for cloud-platform mindshare inside biotech IT.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration26 records

Each record includes

Title, Type, Description, Source

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors22 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Benchling

Biotech R&D Software Platformbenchling.com

Benchling is a cloud-based R&D platform that combines ELN, LIMS, biological registry, and lab automation for biotech and pharmaceutical organizations. It serves 1,300+ customers—including 75% of the top 25 biopharma—and 200,000+ scientists, monetizing via multi-year SaaS subscriptions and reaching $200M ARR in 2024.

What Benchling does

Benchling is a San Francisco-based cloud software company founded in 2012 that provides a unified R&D platform purpose-built for biotechnology and pharmaceutical organizations. Its platform combines electronic lab notebook (ELN), laboratory information management system (LIMS), biological registry, inventory management, molecular biology tools, and workflow automation in a single biologically-aware data model, with 1,300+ customers and 200,000+ scientists using the system, including 75% of the top 25 biopharma companies. The product portfolio spans Benchling Bioresearch (core R&D workspace), Benchling Bioprocess (process development), Benchling Biologics (antibody R&D with no-code format design), Benchling In Vivo (preclinical study management), Benchling Automation (lab instrument connectivity with 200+ integrations), Benchling Connect, Benchling Insights, and Validated Cloud for regulated environments.

The company's technology architecture is built on structured, entity-aware data capture that links experiments, samples, sequences, and results at the point of record, providing the foundation for its 2026 AI suite: Benchling AI, the "AI Scientist" autonomous agent, Model Hub (hosting AlphaFold, Chai-1, Boltz-2, OpenFold), Benchling Inference (managed GPU capacity via Baseten), and MCP-based AI Connectors integrating with Notion, SharePoint, Snowflake, and major LLM providers. Acquisitions of Overwatch Research (2022), PipeBio (2024), and ReSync Bio (2025) extended capabilities into in vivo, antibody bioinformatics, and AI tooling respectively.

Benchling monetizes primarily through multi-year SaaS subscriptions priced per user license, supplemented by tiered Premier and Enterprise Premier success packages, professional services, certified implementation partners, and a free academic tier that seeds enterprise pipeline. Reported ARR is $200M (2024), with a $6.1B last-disclosed valuation. The company is privately held, headquartered at 680 Folsom St. in San Francisco, and maintains SOC 2 Type 2, ISO 27001, GDPR, and FDA 21 CFR Part 11 compliance.

Benchling firmographics

Firmographics
Name
Benchling
Legal name
Benchling
Website
https://benchling.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Benchling is a cloud-based R&D platform that combines ELN, LIMS, biological registry, and lab automation for biotech and pharmaceutical organizations. It serves 1,300+ customers—including 75% of the top 25 biopharma—and 200,000+ scientists, monetizing via multi-year SaaS subscriptions and reaching $200M ARR in 2024.
Ownership category
akta.pro rank

Benchling industry classification

Industry
Product category
Biotech R&D Software Platform
akta.pro industry
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAMAI
Lab Middleware, Instrument Connectivity & Automation
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)

Keywords

  • Lab informatics platform
  • Electronic lab notebook
  • Biotech R&D software
  • Biologics discovery platform
  • Lab automation software

Where Benchling is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Benchling business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS/Cloud Platform Subscription: Benchling operates as a cloud-based SaaS platform for biotech R&D, providing subscription-based access to its integrated ELN, LIMS, molecular biology tools, and AI capabilities. Enterprise pricing varies by organization size and required features.
  2. Professional Services & Implementation: Benchling offers professional implementation services, technical advisory, and architecture reviews through Premier Success Packages. These paid services complement the core platform subscription.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractStandard Success Package
SubscriptionMulti-year contractPremier Success Package
SubscriptionMulti-year contractEnterprise Premier Success Package
FreemiumMonthlyAcademic Free Plan

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Benchling product offering

Product offering

Core offering

Benchling provides a cloud-based R&D platform purpose-built for biotechnology and pharmaceutical research organizations. The platform unifies electronic lab notebook (ELN), laboratory information management system (LIMS), molecular biology design tools, biological registry, inventory management, and workflow automation in a single biologically-aware system. The offering includes AI capabilities, lab automation, and process development tools sold as modular products to enterprise biotech companies, with paid subscription and professional services.

Product overview

Benchling is a cloud-based R&D platform providing a unified, modular architecture for biotech research. The core platform consists of Benchling Bioresearch (digital workspace combining ELN, LIMS, molecular biology tools, registry, and inventory), Benchling Bioprocess (process development for recipe design and batch execution), Benchling AI (unified AI interface with scientific model access and agents), Benchling Biologics (antibody R&D with no-code format design and automated characterization), Benchling In Vivo (in vivo study management), and Benchling Automation (lab instrument connectivity). Supporting modules include Benchling Connect (200+ instrument integrations), Benchling Registry (molecular data management), Benchling Insights (analytics), Model Hub (AI model library), and Benchling Inference (GPU capacity). Acquired brands include PipeBio Antibodies (high-throughput antibody analysis). Solution packages target specific modalities including gene therapy, cell therapy, antibodies, RNA therapeutics, agritech, industrial biotech, and microbial strains. Services include Professional Services, Customer Success, and Learning Labs.

Differentiator

Problem solved

Functional benefit

Brands

  • Benchling Bioresearch: Digital workspace for biotech R&D - electronic lab notebook, sample management, and molecular biology tools
  • Benchling AI
  • Benchling Biologics
  • Benchling Bioprocess
  • Benchling In Vivo
  • Benchling Automation
  • Benchling Registry
  • Benchling Connect
  • PipeBio Antibodies
  • Model Hub
  • One-Click Ordering
  • Benchling Inference
  • Validated Cloud
  • AI Connectors

Products and services

  • Benchling Bioresearch Digital workspace for biotech R&D providing a shared space to design and manage experiments, complex biomolecules, workflows, and results end-to-end. Combines ELN, LIMS, molecular biology tools, biological registry, inventory management, and workflow automation in one platform. Targeted at biotech and pharmaceutical research organizations.
  • Benchling Bioprocess End-to-end process development platform for recipe design, experiment planning, batch execution, and analysis. Built with ISA-88/ASM-compatible data models supporting multi-factor experiments, guided batch execution, and data science readiness. Targeted at bioprocess development teams.
  • Benchling AI Unified AI interface built directly into the Benchling notebook. Scientists describe what they need and Benchling AI handles it, grounded in their own structured R&D data. Includes access to scientific AI models, agents (Notebook Check, SQL Writer, Data Entry Agent, Deep Research Agent, Experiment Optimization), and chat capabilities. Targeted at biotech R&D scientists.
  • Benchling Biologics End-to-end platform for antibody R&D providing no-code antibody format design and automated registration at scale. Features format-aware data model, automated sequence characterization (CDR/FR annotation, germline gene identification, liability detection), and lineage tracking for complex protein formats. Targeted at antibody discovery and protein engineering teams.
  • Benchling In Vivo In vivo study management software for managing preclinical studies from study design and animal randomization through data capture, analysis, and reporting. Replaces paper records and fragmented spreadsheets with modern collaborative digital system. Targeted at preclinical research and animal study teams.
  • Benchling Automation Lab instrument automation platform that connects lab instruments to scientific records, runs analysis automatically, and feeds every result directly into the next decision. Hardware-agnostic with over 200 instrument connectors and visual workflow design. Targeted at labs seeking to automate data capture and analysis.
  • Benchling Registry Comprehensive registry system for modeling, organizing, and recording data for all molecules including biomolecules, small molecules, cell lines, animals, and reagents. Provides molecular lineage tracking, automatic metadata computation (weight, isoelectric point, Log P, TPSA), and uniqueness constraints. Targeted at biotech R&D organizations managing biological entities.
  • Benchling Validated Cloud Compliance-focused cloud offering helping teams move faster without compromising compliance. Provides validation and compliance support for tech transfer between R&D phases and assembles regulatory data packages faster. Supports FDA 21 CFR Part 11 compliance with electronic signatures and audit trails. Targeted at regulated biotech and pharmaceutical customers.
  • Model Hub Dedicated space within Benchling R&D platform for scientists to discover, run, and track scientific AI models alongside experimental data without requiring separate infrastructure. Features curated model library including AlphaFold 2, Chai-1, Boltz-2, OpenFold 2, and OpenFold 3, with 4x increase in prediction speed through upgraded GPU infrastructure. Targeted at biotech R&D scientists.
  • Benchling Inference Scalable GPU capacity service enabling biotech teams to train and run scientific AI models without managing infrastructure. Built on Baseten's inference stack across 15+ cloud providers with 5-10 second cold starts. Targeted at biotech R&D teams needing AI compute capacity.
  • PipeBio Antibodies Bioinformatics platform specializing in high-throughput antibody analysis. Handles upstream sequence analysis including NGS and Sanger data processing, clustering candidates, screening liabilities, and developability scoring. Integrated with Benchling Biologics. Targeted at antibody discovery teams.
  • Customer Success Expert guidance and support services including product training, advisory services, customer success management, and success packages (Standard, Premier, Enterprise Premier) with varying support levels. Targeted at enterprise biotech and pharmaceutical customers.
  • Professional Services Implementation and consulting services covering design and configuration, onboarding and training, integration development, and compliance and validation. Includes support for IQ, OQ, and PQ/UAT requirements. Targeted at enterprise customers deploying Benchling.
  • Benchling Learning Labs Flexible on-demand learning platform offering courses and role-specific badges for Benchling users, administrators, developers, and consultants. Includes learning plans and certification programs. Targeted at Benchling customers and partners.

Quantifiable outcome

  • 63% reduction in time spent on data capture, search, and collection (Gilead)
  • +7 more outcomes

Companies that use Benchling

Customer profile

Named customers20 records

Segments8 records

Ideal customer profiles3 records

Benchling technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration26 records

AI capability11 records

Feature11 records

Benchling partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and flagship.

  • NVIDIA BioNeMo Agent ToolkitcoreTechnology or Integration · 23 June 2026NVIDIA's BioNeMo Agent Toolkit at Bio International Convention transforms LLMs into domain-specific AI agents for end-to-end biology and chemistry workflows. Benchling participates in this ecosystem for AI-driven drug discovery.
  • HighRescoreTechnology or Integration · 28 May 2026HighRes partnership for Benchling Automation, enabling standardized integrations with workcell robotics. The collaboration solves decades-old infrastructure problems for connecting robots to scientific records.
  • AutomatacoreTechnology or Integration · 28 May 2026Automata partnership for Benchling Automation, providing end-to-end lab orchestration capabilities integrated with Benchling's scientific record system.
  • CelltriocoreTechnology or Integration · 28 May 2026Celltrio partnership for Benchling Automation, providing workcell fleet management integrated with Benchling's instrument connectivity.
  • OpentronscoreTechnology or Integration · 28 May 2026Opentrons partnership for Benchling Automation, integrating bench liquid handlers into Benchling's scientific record system for automated data capture.
  • HamiltoncoreTechnology or Integration · 28 May 2026Hamilton partnership for Benchling Automation, integrating advanced liquid handling platforms with Benchling's scientific record and workflow automation.
  • BasetencoreTechnology or Integration · 20 May 2026Benchling and Baseten partnered to launch Benchling Inference, a scalable GPU capacity service enabling biotech teams to train and run scientific AI models without managing infrastructure. Built on Baseten's inference stack across 15+ cloud providers with 5-10 second cold starts.
  • Boltz PBCcoreTechnology or Integration · 13 May 2026Boltz PBC partnership to expand Benchling's curated model library with specialized scientific AI models accessible within Benchling's workflow.
  • Twist BiosciencecoreTechnology or Integration · 6 May 2026Benchling integrated with Twist Bioscience for One-Click Ordering, allowing scientists to design experiments, submit DNA/synthesis orders, and receive structured results without leaving the Benchling platform.
  • AdaptyvcoreTechnology or Integration · 6 May 2026Benchling integrated with Adaptyv for protein engineering services ordering, enabling scientists to design constructs, place orders, and receive structured results directly in the Benchling workflow.
  • Ginkgo BioworkscoreTechnology or Integration · 6 May 2026Benchling integrated with Ginkgo Bioworks for automated data quality and biological services. Integration creates continuous feedback loop tying orders to experimental context with results flowing back as structured, searchable data.
  • Lilly TuneLabcoreStrategic or Co-development Partner · 8 January 2026Benchling announced strategic collaboration with Lilly TuneLab (Eli Lilly's AI/ML platform) to provide predictive research models to scientists. Lilly makes models trained on over $1 billion in research investment available to Benchling's network of 1,300+ biotech companies for antibodies and small molecules.
  • AnthropiccoreTechnology or Integration · 20 October 2025Benchling partnered with Anthropic to integrate Claude AI into biotech research through the Claude for Life Sciences Ecosystem. The collaboration enables scientists to utilize AI for data analysis, decision-making, and research workflow automation.
  • NVIDIAcoreTechnology or Integration · 14 October 2025NVIDIA partnership for AI infrastructure, including integration with NVIDIA BioNeMo models and GPU capacity for Benchling's scientific AI capabilities.
  • ReSync BiocoreStrategic or Co-development Partner · 21 August 2025Benchling acquired ReSync Bio, which provided scientists with no-code access to advanced AI tools through partnerships and open-source tools like Boltz and REINVENT4. ReSync sunset its platform and transitioned customers to Benchling.
  • MerckcoreStrategic or Co-development Partner · 11 June 2025Benchling and Merck collaboration on vaccine bioanalysis, implementing an integrated software platform for bioanalytical workflows focusing on increasing speed, streamlining processes, and maintaining standards in vaccine development.
  • ModernaflagshipStrategic or Co-development Partner · 7 May 2025Benchling and Moderna expanded collaboration to bring hundreds of Moderna scientists onto a unified, AI-ready R&D digital platform. Focus on consolidating research systems, automating scientific workflows, and standardizing data into AI-ready formats as a digital transformation initiative.
  • PipeBiocoreStrategic or Co-development Partner · 20 October 2024Benchling acquired PipeBio, a bioinformatics company specializing in high-throughput antibody analysis. The acquisition integrates PipeBio's capabilities in antibody screening and AI-driven analysis to enhance Benchling's biologics discovery platform for drug discovery and design.
  • NovonesiscoreStrategic or Co-development Partner · 10 October 2024Benchling and Novonesis forged a long-term partnership to power R&D innovation. Novonesis, a major biosolutions company, uses Benchling across 1,500 employees globally to accelerate research.
  • Overwatch ResearchcoreStrategic or Co-development Partner · 24 February 2022Benchling acquired Overwatch Research, a Belfast-based software startup focused on preclinical biopharma research. The acquisition aimed to develop a comprehensive in vivo solution for drug discovery, accelerate preclinical development, and expand Benchling's European presence.

Scale indicators12 records

Recent moves6 records

Expansion highlights7 records

Benchling competitors and assessment

Company assessment

Direct peers

  • Dotmatics: Dotmatics provides a scientific R&D data platform spanning ELN, LIMS, and data lakes for life sciences. Both Benchling and Dotmatics are explicitly building in the 'experimental data lake' space for biotech R&D, making them the most direct competitors in the unified R&D informatics category.
  • LabWare: LabWare is a long-standing LIMS/ELN provider used by many life sciences organizations. It directly competes with Benchling's Bioresearch and Bioprocess modules, particularly in regulated and process-development environments.
  • LabVantage: LabVantage delivers LIMS and laboratory informatics solutions to pharma, biotech, and manufacturing customers. It is a frequent enterprise alternative to Benchling in LIMS-heavy deployments.
  • Genedata: Genedata provides scientific informatics platforms for biopharma R&D, including biologics, screening, and bioprocess workflows. Its domain-specialized approach makes it one of the closest direct competitors to Benchling Biologics and Bioprocess.
  • Sapio Sciences: Sapio Sciences offers a unified lab informatics platform combining LIMS, ELN, SDMS, and scientific data management. Its platform strategy overlaps directly with Benchling's unified biology-aware approach.
  • IDBS (Revvity): IDBS provides ELN and scientific data management software for biopharma R&D, now part of Revvity (formerly PerkinElmer). It competes in the same biological R&D informatics category as Benchling, especially with enterprise biopharma.
  • Arxspan (Certara): Arxspan, part of Certara, provides cloud-based electronic lab notebook and scientific data management software. It targets the same biology and chemistry research lab segments as Benchling Bioresearch.

Broad incumbents

  • Revvity: Revvity is a large life sciences and diagnostics company with an informatics portfolio (including IDBS). As a broad incumbent, it can bundle informatics with instruments, reagents, and services in ways Benchling cannot match from a pure-software position.
  • Thermo Fisher Scientific: Thermo Fisher offers informatics products such as SampleManager and Chromeleon, alongside the industry's broadest lab-instrument portfolio. It competes with Benchling especially in instrument-connected workflows and within large-pharma accounts.

Others

  • Veeva Systems: Veeva is a leading cloud platform for life sciences with regulatory, clinical, and quality solutions. While not a direct R&D informatics competitor, it shares the same strategic customer base (top biopharma) and competes for cloud-platform mindshare inside biotech IT.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Benchling social profiles

Digital presence

Benchling compliance and trust

Trust signal

Compliance5 records

Benchling financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Benchling leadership team

Management profile

Number of profiles

Profiles18 records

Benchling subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Benchling funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Benchling M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Benchling

What does Benchling do?

Benchling provides a cloud-based R&D platform purpose-built for biotechnology and pharmaceutical research organizations. The platform unifies electronic lab notebook (ELN), laboratory information management system (LIMS), molecular biology design tools, biological registry, inventory management, and workflow automation in a single biologically-aware system. The offering includes AI capabilities, lab automation, and process development tools sold as modular products to enterprise biotech companies, with paid subscription and professional services.

Is Benchling a public or private company?

Benchling is a private company. It is classified as venture growth investor backed and is currently operating.

When was Benchling founded?

Benchling was founded in 2012. It employs 501 to 1,000 people.

Where is Benchling based?

Benchling is headquartered in San Francisco, United States, in the North America region.

How does Benchling make money?

Two revenue lines are on record. SaaS/Cloud Platform Subscription is the primary driver. The others are professional Services & Implementation.

Who are Benchling's main competitors?

Direct peers on record are Dotmatics, LabWare, LabVantage, Genedata, Sapio Sciences, IDBS (Revvity) and Arxspan (Certara). Broad incumbents are Revvity and Thermo Fisher Scientific. Veeva Systems is listed as an others.

Does Benchling have an API?

Yes. Benchling's REST APIs and Events make it the hub of a connected R&D ecosystem, enabling easy connection of data with best-in-class instruments, software, and out-of-the-box integrations. The API supports SQL data warehouse access for structured data queries including entity metadata, assay results, and workflow tasks. Python support is available for Custom Code within Benchling. Benchling also supports Model Context Protocol (MCP) for connecting AI tools and data systems. Developer documentation is at docs.benchling.com/docs/developer-platform-overview.

What industry is Benchling in?

Benchling's product category is Biotech R&D Software Platform. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLACAMAI, Lab Middleware, Instrument Connectivity & Automation.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerNVIDIA Corporation Collaborates With UW Medicine Institute For Protein Design, Siemens Healthineers, Automata, Benchling, Biolevate, Boltz, Danaher, Hologen And Therna Biosciences To Advance Drug Discovery And Expand Patient CareNVIDIA announced collaborations with UW Medicine, Siemens Healthineers, and other partners to advance drug discovery and patient care. The company debuted RFD4-Proteina, an open model for protein design, which outperformed baselines in four benchmark suites. Partners are integrating the model into workflows for adaptive radiotherapy and clinical trial design.PR NewswireBenchling launches Science Foundries, a new way for scientists and agents to work togetherBenchling launched Science Foundries, a platform for agents and scientists to run end-to-end scientific workflows. A pharma team now automates antibody design, synthesis, and testing, with agents executing steps and surfacing decisions. Customers can set up their own Foundries starting today.PR NewswireBenchling launches Direct Data Share, Closing the Loop Between the Lab and the AI Data Cloud on SnowflakeBenchling announced Direct Data Share, a Snowflake integration that keeps scientific data continuously connected between Benchling and a company's Snowflake environment. The feature enables bi-directional data flow, with experimental data landing as ready-to-query tables refreshed in near real time. It is now available in public beta for Benchling customers.TumblrTop 7 ELN Systems Biotech Teams Actually Stick With – @nirdosh-jagota on TumblrSeven ELN systems—Benchling, Signals Notebook, Labguru, SciNote, RSpace, Dotmatics, and eLabFTW—are evaluated for long-term biotech adoption. Stickiness depends on fast daily use, strong linking, reliable uptime, and export-ready records, with vendor lock-in avoided by keeping raw data outside the ELN.EIN PresswireLaboratory Information Management Systems Market to reach USD 1,683.0 Million by 2035 at 10.3% CAGRThe global Laboratory Information Management Systems market is projected to grow from USD 631.4 million in 2025 to USD 1,683.0 million by 2035, a CAGR of 10.3%. Growth is driven by regulatory enforcement, cloud deployment, and biologics pipeline expansion, with North America holding 33% of the market.Built In San FranciscoHow Benchling Celebrates Success to Inspire Q4 Wins and Set Goals for the New YearBenchling's sales team uses year-end incentives, pipeline generation, and deal reviews to close opportunities and set Q1 goals. The company also recognizes employees through Leadership Principle Awards and equity compensation, and highlights small wins to maintain momentum.TipranksBenchling Highlights AI-Ready Chemistry Data Strategy After ACS EventBenchling engaged chemists at the ACS meeting to discuss AI-ready data across chemistry workflows. The company promotes a C&EN webinar on September 1 covering structured data capture for chemistry. This signals Benchling's intent to deepen its role as a core data infrastructure provider in life sciences and chemistry.RdworldonlineBenchling envisions vibe coding cutting R&D app development time from months to minutesSan Francisco-based Benchling announced on August 10 vibe coding capabilities, followed by the BenchBench-Protocol benchmark and Benchling Agents, aiming to let scientists build R&D apps in minutes rather than months. Benchling says open models perform similarly to frontier models, and plans to turn pharma data into verifiable rewards for training. Larus-Stone said human oversight remains essential as each automation run costs tens of thousands of dollars.TipranksBenchling Expands R&D Platform With AI-Powered Workflow AgentsBenchling introduced Benchling Agents, an AI-driven assistant that autonomously monitors workflows and takes actions in the background. The feature includes use cases like reviewing candidates and checking study designs, with setup in minutes. The company aims to deepen platform value through embedded AI, potentially increasing customer stickiness and pricing power.TipranksBenchling Highlights AI-Focused R&D Discussion with Former Amgen CTOBenchling will host former Amgen CTO David Reese at its Benchtalk event to discuss AI in biopharma R&D. Reese expects AI's impact to come from incremental adoption of tools improving experiments and data quality, not a single breakthrough. The event aims to reinforce Benchling's position as an enabling platform for data-driven R&D.